Compare JFrog Ltd. Ordinary Shares (FROG) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JFrog Ltd. Ordinary Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? JFrog Ltd. Ordinary Shares trades at $101.54 (market cap $11.99B), while Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B). The key difference: JFrog Ltd. Ordinary Shares and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,116,446). Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FROG | HALO | |
|---|---|---|
Market Cap | $11.99B | $12.58B |
Volume | 1,116,446 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $104.03 | $115.22 |
52-Week Low | $34.75 | $61.63 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $11.18B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About JFrog Ltd. Ordinary Shares
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
